For example, a mini PC is a small-form factor (SFF) device. See form factor and mini PC. THIS DEFINITION IS FOR PERSONAL USE ONLY. All other reproduction requires permission.

An imposing figure, HP's 400-series MFP stands 17 inches tall, but needs almost 10 inches more than that for accessing its scanner and copier bed. Its squarish footprint occupies about 14 by 16 ...

These are our favorite HP laptops from the company's OmniBook, Pavilion, Envy, Spectre and Transcend lines -- all tested and reviewed by CNET editors. Matt Elliott is a senior editor at CNET with ...

Not all employees need or want laptops. If you're looking for desktop PCs for your company—whether just a few or a whole fleet—start with our buying advice and top-rated recommendations.

So whether you're looking for a svelte gaming rig or a versatile 2-in-1 that can be used for work and play, here are the best HP laptop deals you can get right now. HP is currently offering up to ...

Whether you're after a MacBook, Windows PC or Chromebook, these are the best laptops we've tested and reviewed, including the best laptop overall. Matt Elliott is a senior editor at CNET with a ...

Sure, it's possible to spend plenty on a small-form-factor desktop ... buyers want tons of expandability and upgradability. HP's Z2 Mini G9 doesn't have those, but it has awesome performance ...

HP — Hewlett Packard — is huge: It's the name on nearly 20% of every computer sold in 2023, placing it second behind Lenovo ...

Making The Forbes 400 is hard enough. But staying on it might be even tougher. With markets surging and upstarts like Nvidia and Palantir on the rise, the minimum net worth needed to rank among ...

2、除了以上三款燃油车外，在本届上海车展亮相的燃油车还有福特Bronco、马自达CX-50、凯迪拉克GT全新宝马X全新红旗H东风标致408X、坦克400、全新雅阁、全新奔驰GLC、江铃大道等。3、今天，我们就来一起前瞻一下，看看今年这些值得期待的重磅新车。 问坦克400是 ...

An IT dividend share will likely remain in focus in the upcoming month for a 400 per cent dividend payout to its shareholders ...

Oct 1 (Reuters) - Kailera Therapeutics launched on Tuesday as the latest startup seeking a slice of the booming market for anti-obesity therapies with a rare $400 million in early-stage funding.